Literature DB >> 1378753

Expression of the PAX2 gene in human fetal kidney and Wilms' tumor.

M R Eccles1, L J Wallis, A E Fidler, N K Spurr, P J Goodfellow, A E Reeve.   

Abstract

We have examined the pattern of expression of the human PAX2 gene in Wilms' tumors and human fetal kidney by Northern blot and in situ hybridization. Human PAX2 encodes a paired box-containing protein and has a high degree of homology with mouse and Drosophila paired box genes. In situ hybridization analysis reveals that PAX2 is expressed in nephrogenic structures in fetal kidney and also in Wilms' tumors. This pattern of expression suggests that PAX2 may have a role in differentiation of tissues in the kidney. In fetal kidney, PAX2 expression rapidly attenuates following the initial differentiation, but no evidence of attenuation was found in Wilms' tumors. The timing of PAX2 expression is restricted to fetal development, although high levels of expression were also observed in nephrogenic rests of residual normal juvenile kidney tissue adjacent to a Wilms' tumor. Nephrogenic rests are the presumptive precursors of Wilms' tumor but are not necessarily neoplastic. The failure of PAX2 expression to attenuate in Wilms' tumors and nephrogenic rests may be associated with events leading to the onset of Wilms' tumor. By somatic cell hybrid mapping, the PAX2 gene was localized to chromosome 10q22.1-q24.3, although this region has not previously been implicated in Wilms' tumor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1378753

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  30 in total

1.  Localisation of a 10q breakpoint within the PAX2 gene in a patient with a de novo t(10;13) translocation and optic nerve coloboma-renal disease.

Authors:  K Narahara; E Baker; S Ito; Y Yokoyama; S Yu; D Hewitt; G R Sutherland; M R Eccles; R I Richards
Journal:  J Med Genet       Date:  1997-03       Impact factor: 6.318

2.  Expression of Pax2 in human renal tumor-derived endothelial cells sustains apoptosis resistance and angiogenesis.

Authors:  Valentina Fonsato; Stefano Buttiglieri; Maria Chiara Deregibus; Valeria Puntorieri; Benedetta Bussolati; Giovanni Camussi
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

3.  Short-term urinary flow impairment deregulates PAX2 and PCNA expression and cell survival in fetal sheep kidneys.

Authors:  R Attar; F Quinn; P J Winyard; P D Mouriquand; P Foxall; M A Hanson; A S Woolf
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

4.  Clinical utility gene card for: renal coloboma (Papillorenal) syndrome.

Authors:  Matthew Bower; Michael Eccles; Laurence Heidet; Lisa A Schimmenti
Journal:  Eur J Hum Genet       Date:  2011-02-16       Impact factor: 4.246

5.  Analysis of WT1 gene expression during mouse nephrogenesis in organ culture.

Authors:  H Yeger; D Forget; J Alami; B R Williams
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-09       Impact factor: 2.416

6.  Evaluation of metanephric maturation in a human fetal kidney explant model.

Authors:  D G Matsell; T Bennett
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-02       Impact factor: 2.416

7.  PAX2 polymorphisms and congenital abnormalities of the kidney and urinary tract in a Brazilian pediatric population: evidence for a role in vesicoureteral reflux.

Authors:  Débora Marques de Miranda; Augusto César Soares Dos Santos Júnior; Geisilaine Soares Dos Reis; Izabella Silva Freitas; Thiago Guimarães Rosa Carvalho; Luiz Armando Cunha de Marco; Eduardo Araújo Oliveira; Ana Cristina Simões E Silva
Journal:  Mol Diagn Ther       Date:  2014-08       Impact factor: 4.074

8.  Further delineation of renal-coloboma syndrome in patients with extreme variability of phenotype and identical PAX2 mutations.

Authors:  L A Schimmenti; H E Cunliffe; L A McNoe; T A Ward; M C French; H H Shim; Y H Zhang; W Proesmans; A Leys; K A Byerly; S R Braddock; M Masuno; K Imaizumi; K Devriendt; M R Eccles
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

9.  Absence of PAX2 gene mutations in patients with primary familial vesicoureteric reflux.

Authors:  K L Choi; L A McNoe; M C French; P J Guilford; M R Eccles
Journal:  J Med Genet       Date:  1998-04       Impact factor: 6.318

10.  Inhibition of Pax2 Transcription Activation with a Small Molecule that Targets the DNA Binding Domain.

Authors:  Edward Grimley; Chenzhong Liao; Egon J Ranghini; Zaneta Nikolovska-Coleska; Gregory R Dressler
Journal:  ACS Chem Biol       Date:  2017-01-24       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.